<DOC>
	<DOCNO>NCT00658411</DOCNO>
	<brief_summary>The objective research study determine safety feasibility chelation therapy deferoxamine patient iron overload receive stem cell transplant . Patients iron overload prior stem cell transplantation may toxicity transplantation procedure , thus may benefit attempt iron chelation pre- peri-transplantation . In study examine use deferoxamine start 2 week 3 month prior transplantation continue preparative regimen .</brief_summary>
	<brief_title>Deferoxamine Iron Overload Before Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description>See</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>18 year age old Histologically confirm acute myeloid leukemia , acute lymphoblastic leukemia , myelodysplastic syndrome Planned allogeneic stem cell transplantation myeloablative conditioning regimen ; plan date transplantation must least 4 week time enrollment Severe iron overload define BOTH : Ferritin great 1000ng/ml ( time donor availability ) Liver iron content estimate great equal 5mg/g dry weight MRI ( time donor availability ) Patients history prior autologous transplantation eligible study Contraindication magnetic resonance imaging ( MRI ) Creatinine &gt; 2.0mg/dl creatinine clearance &lt; 50ml/min Active uncontrolled bacterial fungal infection History mucormycosis Preexisting clinically apparent retinal neuropathy . If patient clinically apparent visual loss time screening , exclude either known retinal neuropathy exclude test Preexisting clinically apparent sensorineural hearing loss . If patient auditory loss time screening , exclude either known sensorineural hearing loss , exclude test Pregnancy inability unwillingness use contraception time study Lactating patient Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>AML</keyword>
	<keyword>ALL</keyword>
	<keyword>MDS</keyword>
	<keyword>iron overload</keyword>
	<keyword>deferoxamine</keyword>
</DOC>